REFERENCES
- Mann MJ, Dzau Vi. Therapeutic application of transcription factor decoy oligonucleotides. J Clin Invest 2000; 106: 1071–1073
- Mann M, Whittemore AD, Donaldson MC, Belkin M, Conte MS, Polack JF, Orav EJ, Ehsan A, Dell'Acqua G, Dzau VJ. Ex vivo gene therapy of vascular bypass graft with E2F decoy: The PREVENT single-centre, randomized, controlled trial. Lancet 1999; 354: 1493–1498
- Davis JR. The mitogen-activated protein kinase signal transduction pathway.] Biol Chem 1993; 268: 14553–14556
- Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Res 2001; 81: 807–869
- Hagedorn M, Zilberberg L, Lozano RM, Cuevas P, Canron X, Redondo-Horcajo M, Giménez-Gallego G, Bikfalvi A. A. short peptide domain of platelet factor 4 blocks angiogenic key events induced by FGF-2. FASEB J 2001; 15: 550-552
- Cuevas P, Diaz-Gonzalez D, Dujovny M. Antiproliferative effect of neomycin in glioma cells. Neurol Res 2002; 24: 389–391
- López-Toledano M. Generacieri de células catecolaminiErgicas a partir de células tronco neurales expandidas en cultivo. Doctoral Thesis (unpublished)2001. Facultad de Biologia, Departamento de Biologia Celular, Universidad Complutense Madrid, Spain
- Fisher ML, Liu B, Glennon PE, Southgate KM, Sale EM, Sale GJ, Lewis MJ, Groves PH. Down regulation of the ERK1 and ERK2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle cells. Atherosclerosis 2001; 156: 289-295
- Chattopadhyay N, Tfeit-Hansen J, Brown EM. PKC, p42/44 MAPK and p38 MAPK regulate hepatocyte growth factor secretion from human astrocytoma cells. Mol Brain Res 2002; 102: 73–82
- Park YG, Nesterovat M, Agrawal S, Cho-Chung YS. Dual blockade of cyclic AMP response element (CRE) and AP-1-directed transcription by CRE-transcription factor decoy digonucleotide. Gene-specific inhibition of tumor growth.] Biol Chem 1999; 274: 1573–1580
- Chou inard N, Valerie K, Rouabhia M, Huot J. UVB-mediated activation of p38 mitogen-activated protein kinase enhances resistance of normal human keratinocytes to apoptosis by stabilizing cytoplasmic p53. BiochemJ 2002; 365: 133–145
- Hu G-F. Neomycin inhibits the angiogenicactivity of fibroblast and epidermal growth factors. Biochem Biophys Res Commun 2001; 287: 870–874
- Eliceiri BP, Klemke R, Stromb lad S, Cheresh DA. lntegrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. I Coll Biol 1998; 140: 1255-1263
- D'Angelo G, Stru man I, Martial J, Weiner ft. Activation of m itogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDA N-term inal fragment of prolactin. Proc Nat/ Acad Sci USA 1995; 92: 6374–6378
- Red litz A, Daum G, Sage EH. Angiostatin diminishes activation of the mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular endothelial cells. J Vasc Res 1999; 36: 28–34
- Levitzki A, Gazit A. Tyrosine kinase inhibition: An approach to drug development. Science 1995; 267: 1782–1788
- English JM, Cobb MH. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol Sci 2002; 23: 40–45